Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

March 2010
1. LEE KS , Lee YS, Lee JM, Ito K, et al
   Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. ASNAGHI L , Vass WC, Quadri R, Day PM, et al
   E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. IEJIMA D , Minegishi Y, Takenaka K, Siswanto A, et al
   FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. XU L , Nilsson MB, Saintigny P, Cascone T, et al
   Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LENFERINK AE , Cantin C, Nantel A, Wang E, et al
   Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
   Oncogene. 2010;29:831-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
6. IBANEZ DE CACERES I , Cortes-Sempere M, Moratilla C, Machado-Pinilla R, et al
   IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. KOMIYA T , Coxon A, Park Y, Chen WD, et al
   Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. KIM YH , Kwei KA, Girard L, Salari K, et al
   Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LIANG MC , Ma J, Chen L, Kozlowski P, et al
   TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
10. LI Y , Ye X, Tan C, Hongo JA, et al
    Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.
    Oncogene. 2009;28:3442-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
11. EBI H , Sato T, Sugito N, Hosono Y, et al
    Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.
    Oncogene. 2009;28:3371-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
12. SWITZER CH , Ridnour LA, Cheng RY, Sparatore A, et al
    Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CONFALONIERI S , Quarto M, Goisis G, Nuciforo P, et al
    Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
    Oncogene. 2009;28:2959-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. YUAN BZ , Chapman J, Reynolds SH
    Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KELLY-SPRATT KS , Philipp-Staheli J, Gurley KE, Hoon-Kim K, et al
    Inhibition of PI-3K restores nuclear p27(Kip1) expression in a mouse model of Kras-driven lung cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. SPORN JC , Kustatscher G, Hothorn T, Collado M, et al
    Histone macroH2A isoforms predict the risk of lung cancer recurrence.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. BURRIS HA 3RD
    Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
    Oncogene. 2009;28 Suppl 1:S4-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. PEREZ-SOLER R
    Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
    Oncogene. 2009;28 Suppl 1:S38-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HIRSCH FR , Varella-Garcia M, Cappuzzo F
    Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer.
    Oncogene. 2009;28 Suppl 1:S32-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. GAZDAR AF
    Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.
    Oncogene. 2009;28 Suppl 1:S24-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. JOHN T , Liu G, Tsao MS
    Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
    Oncogene. 2009;28 Suppl 1:S14-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. HIRSCH FR
    The role of genetic testing in the prediction of response to EGFR inhibitors in NSCLC.
    Oncogene. 2009;28 Suppl 1:S1-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
23. SHER YP , Tzeng TF, Kan SF, Hsu J, et al
    Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
24. HOENERHOFF MJ , Chu I, Barkan D, Liu ZY, et al
    BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. CHITALE D , Gong Y, Taylor BS, Broderick S, et al
    An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. DYDENSBORG AB , Rose AA, Wilson BJ, Grote D, et al
    GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
27. NALBANDIAN A , Yan BS, Pichugin A, Bronson RT, et al
    Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control.
    Oncogene. 2009;28:1928-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. AKIRI G , Cherian MM, Vijayakumar S, Liu G, et al
    Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
29. CHUNG BM , Dimri M, George M, Reddi AL, et al
    The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HO VM , Schaffer BE, Karnezis AN, Park KS, et al
    The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras.
    Oncogene. 2009;28:1393-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
31. TANG Z , Jiang S, Du R, Petri ET, et al
    Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
    Oncogene. 2009;28:518-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. GUIGON CJ , Zhao L, Willingham MC, Cheng SY, et al
    PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
    Oncogene. 2009;28:509-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. KIM HJ , Kim YM, Lim S, Nam YK, et al
    Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.
    Oncogene. 2009;28:117-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
34. LI S , Szymborski A, Miron MJ, Marcellus R, et al
    The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells.
    Oncogene. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
35. MANENTI G , Trincucci G, Pettinicchio A, Amendola E, et al
    Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.
    Oncogene. 2008;27:5753-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. CALVO A , Catena R, Noble MS, Carbott D, et al
    Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Oncogene. 2008;27:5373-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
37. NAVAB R , Pedraza C, Fallavollita L, Wang N, et al
    Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.
    Oncogene. 2008;27:4973-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
38. IMPENS F , Van Damme P, Demol H, Van Damme J, et al
    Mechanistic insight into taxol-induced cell death.
    Oncogene. 2008;27:4580-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. LOCKWOOD WW , Chari R, Coe BP, Girard L, et al
    DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers.
    Oncogene. 2008;27:4615-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. LIN J , Arlinghaus R
    Activated c-Abl tyrosine kinase in malignant solid tumors.
    Oncogene. 2008;27:4385-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. TSENG RC , Lin RK, Wen CK, Tseng C, et al
    Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
    Oncogene. 2008;27:4488-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. VASILJEVA O , Korovin M, Gajda M, Brodoefel H, et al
    Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
    Oncogene. 2008;27:4191-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. WANG IC , Meliton L, Tretiakova M, Costa RH, et al
    Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors.
    Oncogene. 2008;27:4137-49.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
44. GOUYER V , Fontaine D, Dumont P, de Wever O, et al
    Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.
    Oncogene. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: